Harvis Pharm (P) Ltd.

Company Description

Harvis Pharm (P) Ltd., based in India, is a supplier of APIs & Generics in the International markets.

Harvis Pharm (P) Ltd. supply APIs for regulated and semi-regulated markets, produced by cGMP manufcturers. DMFs/CTDs/COS is made available as per market requirements. Patent non-infringing processes are followed as necessary.

In the finished pharmaceuticals, one of our special areas of interest is Oncological generics.

We supply our Branded and Unbranded generics in the Oncology segment, in Oral and Injectable Dosage Forms to patent-free markets. Our products are produced under contract manufacturing arrangements with GMP sites.
For our generic formulations, WHO-GMP certification, COPPs, and appropriate Dossiers are available.
Our key generics are DOTAXEL( Docetaxel 20/80/120mg) PAXXOL( Paclitaxel 30,100,150,260,300mg), DOEMZAR( Gemcitabine Lyo vials 200,1000mg), DOXATIN( Oxaliplatin ) DOCAPEX ( Capecitabine Tablets 150,500mg) DOMIDEX( Anastrazole 1mg Tabs) DOMOZOL( temozolomide capsules 5,20,100,250mg).
Unbranded versions of these generics and also other oncology products are available in our portfolio.